rs7565788

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_004525.3(LRP2):​c.10393+318A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.752 in 151,968 control chromosomes in the GnomAD database, including 43,217 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.75 ( 43217 hom., cov: 31)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.752

Publications

4 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • congenital heart disease
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 2-169177485-T-C is Benign according to our data. Variant chr2-169177485-T-C is described in ClinVar as Benign. ClinVar VariationId is 1279171.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.10393+318A>G
intron
N/ANP_004516.2P98164

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.10393+318A>G
intron
N/AENSP00000496870.1P98164
LRP2
ENST00000649153.1
n.1291+318A>G
intron
N/AENSP00000497617.1A0A3B3IT64

Frequencies

GnomAD3 genomes
AF:
0.752
AC:
114254
AN:
151852
Hom.:
43180
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.759
Gnomad AMI
AF:
0.721
Gnomad AMR
AF:
0.787
Gnomad ASJ
AF:
0.740
Gnomad EAS
AF:
0.500
Gnomad SAS
AF:
0.856
Gnomad FIN
AF:
0.714
Gnomad MID
AF:
0.832
Gnomad NFE
AF:
0.759
Gnomad OTH
AF:
0.766
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.752
AC:
114352
AN:
151968
Hom.:
43217
Cov.:
31
AF XY:
0.752
AC XY:
55828
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.759
AC:
31478
AN:
41450
American (AMR)
AF:
0.787
AC:
12015
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.740
AC:
2566
AN:
3468
East Asian (EAS)
AF:
0.501
AC:
2596
AN:
5178
South Asian (SAS)
AF:
0.855
AC:
4119
AN:
4820
European-Finnish (FIN)
AF:
0.714
AC:
7515
AN:
10520
Middle Eastern (MID)
AF:
0.833
AC:
245
AN:
294
European-Non Finnish (NFE)
AF:
0.759
AC:
51542
AN:
67950
Other (OTH)
AF:
0.768
AC:
1620
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1476
2953
4429
5906
7382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.762
Hom.:
22022
Bravo
AF:
0.752
Asia WGS
AF:
0.712
AC:
2474
AN:
3474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.30
DANN
Benign
0.41
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7565788; hg19: chr2-170033995; API